Protagonist Therapeutics Virtual KOL Event following ASH
Please join Protagonist Therapeutics management for a Virtual KOL Event following the presentation of PTG-300 data in Polycythemia Vera at the ASH Annual Meeting.
Date: Wednesday, December 9th
Time: 8:30-9:30am ET
Dial-In Details: 1-844-515-9178 (U.S./Canada), 1-614-999-9313 (International) and refer to Conference ID number 8794865. A live and archived webcast will also be accessible in the Investors section of the Company’s website at www.protagonist-inc.com
Featured KOL Speaker: Andrew Kuykendall, M.D., PTG-300 study investigator and member of the Department of Malignant Hematology at the Moffitt Cancer Center
Additional information on Protagonist’s oral and poster presentations at ASH can be found here.
Please RSVP to Rebecca John rjohn@troutgroup.com or Alexandra Roy aroy@troutgroup.com